Stauffer’s Syndrome in Patient with Metastatic Prostate Cancer

Table 1

Laboratory findings during hospitalization.

Analysis	Day 1	Day 7	Day 14	Reference range	5 months prior to admission date
ALT,U/L	235	59	33	10-49	19
AST, U/L	161	51	88	0-33	32
Bilirubin, umol/L	165	162	299	5-21	13
Direct-bilirubin, umol/L	132	133	237	0-5	4
Indirect-bilirubin, umol/L	33	29	63	0-16	9
Testosterone, ng/dL			12.76	86.49-788.22
Alkaline phosphatase U/L	2513	1416	934	46-116	1356
Alkaline phosphatase bone fraction (ALP2), U/L			366	5.5-22.9
LDH, U/L		350	592	120-246
GGT, U/L	1174	515	361	0-72
CRP, mg/L	24.67	36.2	267.76	0-5	3.6
IL-6, pg/mL			57	<3.4
PSA, ng/mL		66.01	91.78	0-3.99
APTT, sec.	36.3	41.8	46.1	26-36	39.5
Prothrombin index,%	87.6	18.4	20.7	70-120	74.5
INR	1.06	3.16	2.88	0.8-1.2	1.14
Fibrinogen, g/L	5.73	8.58	8.68	0-0.5	1.68

ALT- alanine aminotransferase; AST- aspartate transaminase; GGT- gamma-glutamyl transferase; CRP- C reactive protein; IL-6- interleukin 6; LDH- lactate dehydrogenase; PSA – prostate specific antigen; APTT – activated partial thromboplastin time; INR – international normalized ratio of prothrombin time of blood coagulation.